MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-19-0120876
Surmount Laboratories Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹95.33 Cr
▼ 6% YoY
Net profit · FY 2024
₹8.42 Cr
Net margin 8.8%
EBITDA · FY 2024
₹13.33 Cr
EBITDA margin 14%
Authorised capital
₹6 Cr
Registered with MCA
Paid-up capital
₹4.72 Cr
Issued & subscribed
Open charges
₹24 Cr
Satisfied ₹24.8 Cr
Company age
30 yrs
Est. 1996
Employees · EPFO
19
Provident fund records
About Surmount Laboratories Limited
Data last updated:
Surmount Laboratories Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 March 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1996PLC098511. Its GSTIN is 27AAECS0804K1ZF (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹6 Cr and a paid-up capital of ₹4.72 Cr. It is led by directors including Minesh Dhirendra Mehta and Dhirendra Maganlal Mehta.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹95.33 Cr, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹8.42 Cr (net margin 8.8%) and EBITDA of ₹13.33 Cr (EBITDA margin 14%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 8% over five years.
The company has about 19 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Surmount Laboratories. As per MCA filings, the company has open charges of ₹24 Cr and satisfied charges of ₹24.8 Cr on record. Court records list 6 cases involving the company, including 5 filed by the company and 1 filed against it. The company has 10 deals on record (6 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹2.23 Cr; the latest was in October 2022. Its 8 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is V S International Private Limited with revenue of ₹96.26 Cr. The company has 4 MSME Form 1 returns on record between 2019 and 2023, listing 91 overdue payments to 47 micro and small suppliers.
Surmount Laboratories Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0120876). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website surmountlab.com.
Company details
CIN U24230MH1996PLC098511
Registration Number 098511
Incorporation Date 28 March 1996
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-19-0120876
CIN history
Surmount Laboratories has one previous CIN (Corporate Identification Number): U24230MH1996PTC098511. The current CIN is U24230MH1996PLC098511, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230MH1996PLC098511 | Current |
| U24230MH1996PTC098511 | Previous |
Key People
Minesh Dhirendra Mehta Director Dhirendra Maganlal Mehta Director Kavit Dhirendrakumar Mehta Director Recognitions & Rankings of Surmount Laboratories
Contact details
Surmount Laboratories Limited's registered office is in Mumbai, Maharashtra.
- Registered AddressOffice No. 305 Building No. 3 Wing C – 2 Skyline Wealthspace Premises Chsl, Premier Road Millar Compound Vidyavihar West, Mumbai, Maharashtra, India – 400086
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Surmount Laboratories Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Surmount Laboratories operates one associated brand: Surmount Laboratories. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Development, manufacturing, and marketing of pharmaceutical tablets and capsules. | surmountlab.com |
Business activity
The main business activity of Surmount Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Surmount Laboratories Limited, buy the company report.
Financials of Surmount Laboratories Limited
FY 2024 filings availableSurmount Laboratories Limited reported revenue of ₹95.33 Cr (down 6% YoY) for FY 2024.
Revenue · FY 2024
₹95.33 Cr ▼ 6%
Net profit · FY 2024
₹8.42 Cr margin 8.8%
EBITDA · FY 2024
₹13.33 Cr margin 14%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 6%
3 years · compounded
▲ 6%
5 years · compounded
▲ 8%
EBITDA CAGR growth
1 year
▲ 5%
3 years · compounded
▲ 21%
5 years · compounded
▲ 27%
Revenue fell 6% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 8%. EBITDA rose 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹95.33 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹13.33 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.42 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14% | ||||
| Net Profit Margin | 8.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Surmount Laboratories Limited, buy the company report.
Board of directors of Surmount Laboratories Limited
Surmount Laboratories has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Minesh Dhirendra Mehta | Director | 04 Dec 2017 | 8 Years 10 Months | Current |
| Dhirendra Maganlal Mehta Also directs: Surmount Formulations Private Limited | Director | 27 Aug 2020 | 6 Years 1 Months | Current |
| Kavit Dhirendrakumar Mehta Also directs: Surmount Formulations Private Limited | Director | 31 Aug 2022 | 4 Years 1 Months | Current |
Peer comparison
Surmount Laboratories Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| V S International Private Limited | ₹96.26 Cr (FY 2024) | 65.0% | Mumbai, Maharashtra, India | |||
| XL Laboratories Private Limited | ₹96.06 Cr (FY 2025) | 17.0% | New Delhi, Delhi, India | |||
| Yeluri Formulations Private Limited | ₹96.05 Cr (FY 2025) | -23.0% | Hyderabad, Telangana, India | |||
| MCW Healthcare Private Limited | ₹95.35 Cr (FY 2024) | 16.0% | Madhya Pradesh, India | |||
| Surmount Laboratories Limitedthis company | ₹95.33 Cr (FY 2024) | ₹8.42 Cr | 8.8% | -6.0% | Mumbai, Maharashtra, India | |
| Ang Lifesciences India Limited | ₹94.87 Cr (FY 2025) | -35.0% | Amritsar, Punjab, India | |||
| Bio-Med Private Limited | ₹94.67 Cr (FY 2025) | 19.0% | Uttar Pradesh, India | |||
| Impulse Pharma Private Limited | ₹94.61 Cr (FY 2024) | 12.0% | Thane, Maharashtra, India | |||
| Chiron Behring Vaccines Private Limited | ₹94.53 Cr (FY 2025) | 30.0% | Bhor, Maharashtra, India |
To see the full peer comparison of Surmount Laboratories Limited, buy the company report.
Charges & borrowings
Open charges
₹24 Cr
Satisfied charges
₹24.8 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Dec 2023 | 100840948 | Others | ₹50 Lakh | Open | |
| 04 Oct 2022 | 100621256 | Others | ₹6 Cr | Open | |
| 19 Mar 2016 | 100025483 | Others | ₹17.5 Cr | Open | |
| 15 Nov 2022 | 100660651 | Others | ₹15 Cr | Satisfied | |
| 27 Jun 2013 | 10437545 | Punjab National Bank | ₹7 Cr | Satisfied |
To see the full charge records of Surmount Laboratories Limited, buy the company report.
Total charge records: 7 View all charges
Deals & funding
Surmount Laboratories Limited has 10 deals on record (6 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹2.23 Cr; the latest was in October 2022.
Total deals
10
Secondary share transfers
6
Funding rounds
3
Rights issue
1
Disclosed funding
₹2.23 Cr
Deals on record (5 of 10)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2022 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Mar 2018 | Funding round | ₹30 Lakh | Investors: an individual |
| Mar 2017 | Rights issue | ₹24 Lakh | Investors: 2 individuals |
| Jun 2014 | Funding round | ₹1 Cr | Investors: 2 individuals |
| Mar 2006 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: Sterfil Laboratories Private Limited , 3 individuals |
To see the full deal history of Surmount Laboratories Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Surmount Laboratories Limited has 6 court cases on record: 5 filed by Surmount Laboratories, 1 filed against it. All cases are disposed.
Total cases
6
Filed by the company
5
Filed against the company
1
Disposed
6
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 5 | 0 | 0 |
| District courts | 1 | 1 | 0 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Appeal | Filed by the company against Rass Pharma Pvt Ltd | Disposed |
| District court, Bharuch, Gujarat | Court case (REFER T LC) | Filed against the company by an individual | Disposed |
| High Court, GUJARAT | Special civil application | Filed by the company against an individual | Disposed |
| High Court, GUJARAT | Appeal | Filed by the company against an individual | Disposed |
| High Court, GUJARAT | Special civil application | Filed by the company against an individual | Disposed |
To see the full case history of Surmount Laboratories Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Surmount Laboratories Limited has 4 MSME Form 1 returns on record between 2019 and 2023, listing 91 overdue payments to 47 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 47)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Ipca Laboratories Limited | |||
| Sampatti New Life Private Limited | |||
| Aster Biopharma LLP | |||
| an individual supplier |
To see the full MSME payment records of Surmount Laboratories Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Surmount Laboratories has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECS0804K1ZF | Maharashtra | Active | 01 Jul 2017 |
| 24AAECS0804K1ZL | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Surmount Laboratories Limited, buy the company report.
Recent activity
Surmount Laboratories Limited has 10 board changes on record since 2008: 3 appointments and 7 cessations. The latest: Minesh Dhirendra Mehta ceased to be Director Appointed In Casual Vacancy on 29 Sep 2024.
Charges
A charge registered on 15 Nov 2022 via Charge ID 100660651 with Others was fully satisfied on 01 Mar 2025.
Charges
A charge with Others of Rs. 17.50 Cr registered on 19 Mar 2016 with Charge ID 100025483 was modified on 04 Oct 2024.
AGM
Surmount Laboratories Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Minesh Dhirendra Mehta ceased to be Director Appointed In Casual Vacancy.
Filing
Surmount Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge with Others amounted to Rs. 0.50 Cr with Charge ID 100840948 was registered on 15 Dec 2023.
Charges
A charge with Others of Rs. 15.00 Cr registered on 15 Nov 2022 with Charge ID 100660651 was modified on 15 Jul 2023.
Charges
A charge with Others of Rs. 6.00 Cr registered on 04 Oct 2022 with Charge ID 100621256 was modified on 15 Jul 2023.
Charges
A charge with Others amounted to Rs. 15.00 Cr with Charge ID 100660651 was registered on 15 Nov 2022.
Charges
A charge with Others amounted to Rs. 6.00 Cr with Charge ID 100621256 was registered on 04 Oct 2022.
Ceased
Kavit Dhirendrakumar Mehta ceased to be Additional Director.
Appointed
Kavit Dhirendrakumar Mehta was appointed as Director.
16 earlier events are in the company report.
Frequently asked questions
Surmount Laboratories is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 March 1996 (30+ years old) and is registered under CIN U24230MH1996PLC098511.
Surmount Laboratories has 3 current directors:
- Minesh Dhirendra Mehta - Director
- Dhirendra Maganlal Mehta - Director
- Kavit Dhirendrakumar Mehta - Director
The latest financial statements of Surmount Laboratories on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Surmount Laboratories is 27AAECS0804K1ZF, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AAECS0804K1ZL (Gujarat).
The CIN (Corporate Identification Number) of Surmount Laboratories is U24230MH1996PLC098511. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Surmount Laboratories has 6 court cases on record: 5 filed by the company and 1 filed against it. Most are in the high courts.
Surmount Laboratories was incorporated on 28 March 1996, making it 30+ years old. It is registered with the Registrar of Companies, Mumbai.
Surmount Laboratories has 10 deals on record (6 secondary share transfers, 3 funding rounds, 1 rights issue), with disclosed funding of ₹2.23 Cr; the latest was in October 2022.
The peers of Surmount Laboratories by revenue are V S International Private Limited, XL Laboratories Private Limited, Yeluri Formulations Private Limited, MCW Healthcare Private Limited, Ang Lifesciences India Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Minesh Dhirendra Mehta ceased to be Director Appointed In Casual Vacancy on 29 Sep 2024. Kavit Dhirendrakumar Mehta ceased to be Additional Director on 30 Sep 2022. Kavit Dhirendrakumar Mehta was appointed as Director on 31 Aug 2022. Surmount Laboratories has 10 board changes on record in total.
Yes, Surmount Laboratories is registered as a small enterprise under Udyam registration (number: UDYAM-MH-19-0120876).
Surmount Laboratories has 4 MSME Form 1 returns on record between 2019 and 2023, listing 91 overdue payments to 47 micro and small suppliers. The latest return was filed on 23 Apr 2023.